CD8A and cancer: Particularly, in vitro and in vivo studies have shown that macrophages are able to prime an effective CD8+ T cell response following anti-CD47 treatment-mediated phagocytosis of cancer cells, by concomitantly inducing a reduction in regulatory T cell population (Tseng et al., 2013).